User:Tilman Schirmer/Sandbox 201
From Proteopedia
(Difference between revisions)
(→1.5 Allosteric product binding site) |
(→1.4 Substrate binding site) |
||
| Line 25: | Line 25: | ||
<applet load='2v0n' scene='User:Tilman_Schirmer/Sandbox_201/Substrate_binding_site/2' size='300' frame='true' align='right' caption='2v0n' /> | <applet load='2v0n' scene='User:Tilman_Schirmer/Sandbox_201/Substrate_binding_site/2' size='300' frame='true' align='right' caption='2v0n' /> | ||
| - | |||
<scene name='User:Tilman_Schirmer/Sandbox_201/Substrate_binding_site/2'>Substrate binding site</scene> | <scene name='User:Tilman_Schirmer/Sandbox_201/Substrate_binding_site/2'>Substrate binding site</scene> | ||
| - | |||
<scene name='User:Tilman_Schirmer/Sandbox_201/Substrate_binding_ctp-a-s_mg/2'>Substrate binding site + ligand (CTP-alpha-S) + Mg++</scene> | <scene name='User:Tilman_Schirmer/Sandbox_201/Substrate_binding_ctp-a-s_mg/2'>Substrate binding site + ligand (CTP-alpha-S) + Mg++</scene> | ||
Revision as of 13:04, 19 June 2009
Diguanylate cyclases
Contents |
1. PleD
1.1 Intro
1.2 Domain structure
1.3 Protomer
|
: , ,
1.4 Substrate binding site
|
1.5 Allosteric product binding site
|
C-di-GMP
Primary inhibition site (Ip)
Secondary inhibition site (Is)
Primary and secondary inhibition sites
1.6 Two conformations
non-activated (1w25)
activated (BeF3- modified; 2v0n)
|
|
1.7 Non-activated conformation
|
: , ,
1.8 Activated conformation
|
